| Catalog Number |
06L45-22 |
| Medical Device Problem Code |
High Test Results (2457)
|
| Health Effect - Clinical Code |
No Clinical Signs, Symptoms or Conditions (4582)
|
| Date of Event |
12/23/2024
|
|
Type of Reportable Event
|
Malfunction
|
|
Additional Manufacturer Narrative
|
|
Complete entry for section a1 - patient identifier: (b)(6), complete entry for section e1 - phone number: (b)(6).An evaluation is in process.A follow-up report will be submitted when the evaluation is complete.All available patient information was included.Additional patient details are not available.
|
| |
|
Event or Problem Description
|
|
The customer observed a falsely elevated total bilirubin on the architect c4000 processing module for one patient.The following results were provided (reference range, total bilirubin, 0.20 to 1.20 mg/dl): on (b)(6) 2024, sid (b)(6), initial total bilirubin result= 26.36 mg/dl; repeat result= 0.37 mg/dl.There was no impact to patient management reported.
|
| |
|
Event or Problem Description
|
|
The customer observed a falsely elevated total bilirubin on the architect c4000 processing module for one patient.The following results were provided (reference range, total bilirubin, 0.20 to 1.20 mg/dl): (b)(6) 2024, sid (b)(6) , initial total bilirubin result= 26.36 mg/dl; repeat result= 0.37 mg/dl.There was no impact to patient management reported.
|
| |
|
Additional Manufacturer Narrative
|
|
After further evaluation, the suspect medical device was changed from total bilirubin, list number 06l45-22, and manufacturing site abbott gmbh, wiesbaden to architect c4000, list number 02p24-01, and manufacturing site abbott laboratories, irving.Mdr number 3016438761-2025-00037 has been submitted and all further information will be documented under that mdr number.
|
| |
|
Search Alerts/Recalls
|